Nanoparticulate anticancer compositions and methods for making the same
作者： Janine Keller , David Slifer
DOI:
关键词:
摘要: Described are injectable formulations of particulate 3-(2,4-dichloro-phenyl)-l,6- dimethyl-l,9-dihydro-pyrido[2,3-b]indol-2-one that produce a prolonged duration action upon administration, and methods making using such formulations. The comprise 3-(2,4-dichloro-phenyl)-l,6-dimethyl-l,9- dihydro-pyrido[2,3-b]indol-2-one.
google.co.in 参考文章(64)
Angelo Erbeia, New process for preparing pharmaceutical, cosmetic or diagnostic formulations ,(1978)
Baldev Singh, Diagnostic imaging x-ray contrast agents ,(1995)
Lan De Castro, Method of preparing stable drug nanoparticles ,(1995)
Edward R. Bacon, Method of x-ray imaging using iodinated aromatic propanedioates ,(1993)
Shuqian Xu, Sui-Ming Wong, David A. Engers, Stephen B. Ruddy, Mary E. Roberts, Gary G. Liversidge, Methods of treating mammals using nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors ,(1999)
Pranab Bagchi, H. William Bosch, Raymond P. Scaringe, Co-microprecipitation of nanoparticulate pharmaceutical agents with crystal growth modifiers ,(1995)
Natarajan Rajagopalan, George C. Na, Formulations for nanoparticulate x-ray blood pool contrast agents using high molecular weight nonionic surfactants ,(1992)
Siegfried K. June, Use of tyloxapole as a nanoparticle stabilizer and dispersant ,(1992)
David L C O Sterling Wint Ladd, Kenneth R C O Sterli Hollister, George C C O Sterling Winth Na, Natarajan C O Ster Rajagopalan, Barbara O-Ching C O Sterl Yuan, Gregory L C O Sterlin Mcintire, Use of purified surface modifiers to prevent particle aggregation during sterilization ,(1993)
George C C O Sterling Winth Na, Natarajan C O Ster Rajagopalan, Use of ionic cloud point modifiers to prevent particle aggregation during sterilization. ,(1993)